Revenue Climbs, Profits Lag
Colgate-Palmolive India achieved record revenue of ₹1,595 crore in the fourth quarter of fiscal year 2026, marking a 9% increase from the previous year. Despite this topline success, net profit stayed nearly the same as the prior year, reporting ₹353 crore. The company's EBITDA margins narrowed to 31.9% from 35.1% a year earlier. This profit squeeze was driven by rising operational costs and a 10.5% jump in advertising expenses. With a price-to-earnings ratio around 44 times trailing earnings, the market values the company highly, but its struggle to boost profits suggests this valuation could be challenged if operational efficiency doesn't improve.
Growth Strategy Under Scrutiny
Analysts are questioning the company's focus on price increases over volume growth. While Colgate-Palmolive India notes strong performance in its premium segment, which is growing much faster than the rest of its business, sales in rural areas are showing weakness. Unlike diversified competitors such as Hindustan Unilever and Dabur, Colgate's concentration on oral care makes it more sensitive to demand shifts in that specific market. Its recent performance has also lagged behind the wider fast-moving consumer goods (FMCG) sector, indicating investor concerns about its growth sustainability amid ongoing inflation impacting wages and raw material costs.
Facing Competitive and Regulatory Challenges
The company is also dealing with structural issues that add to its vulnerabilities. These include adjustments for tax and compliance matters, such as the inverted duty structure under GST. Past legal issues, including fines for unfair trade practices related to pricing, also contribute to caution among investors. The decision to boost ad spending by 10.5% might be a defense against agile, lower-cost natural and herbal brands that have gained market share. If the premiumization strategy doesn't lead to better profit margins, Colgate could face a cycle of high marketing costs and declining profitability.
What Investors Are Watching
Looking ahead, the key question for Colgate-Palmolive India is whether its premium product sales can truly overcome the inflationary pressures affecting its core business. The board's decision to issue a second interim dividend of ₹24 per share signals confidence, but investors will be focused on whether future results show a clearer link between revenue growth and actual profit. Analysts are closely monitoring the impact of recent organizational changes and the company's ability to sustain sales volume without relying heavily on price hikes.
